210 related articles for article (PubMed ID: 22209415)
1. Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation.
Mielcke TR; Mascarello A; Filippi-Chiela E; Zanin RF; Lenz G; Leal PC; Chiaradia LD; Yunes RA; Nunes RJ; Battastini AM; Morrone FB; Campos MM
Eur J Med Chem; 2012 Feb; 48():255-64. PubMed ID: 22209415
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
[TBL] [Abstract][Full Text] [Related]
3. Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines.
Neves MP; Cravo S; Lima RT; Vasconcelos MH; Nascimento MS; Silva AM; Pinto M; Cidade H; Corrêa AG
Bioorg Med Chem; 2012 Jan; 20(1):25-33. PubMed ID: 22177409
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
[TBL] [Abstract][Full Text] [Related]
5. Quinolinyl and quinolinyl N-oxide chalcones: synthesis, antifungal and cytotoxic activities.
de Carvalho Tavares L; Johann S; Maria de Almeida Alves T; Guerra JC; Maria de Souza-Fagundes E; Cisalpino PS; Bortoluzzi AJ; Caramori GF; de Mattos Piccoli R; Braibante HT; Braibante ME; Pizzolatti MG
Eur J Med Chem; 2011 Sep; 46(9):4448-56. PubMed ID: 21816519
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect.
Vogel S; Barbic M; Jürgenliemk G; Heilmann J
Eur J Med Chem; 2010 Jun; 45(6):2206-13. PubMed ID: 20153559
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
8. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying the antiproliferative effects of a series of quinoxaline-derived chalcones.
Mielcke TR; Muradás TC; Filippi-Chiela EC; Amaral MEA; Kist LW; Bogo MR; Mascarello A; Neuenfeldt PD; Nunes RJ; Campos MM
Sci Rep; 2017 Nov; 7(1):15850. PubMed ID: 29158524
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines.
Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; Licínio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC
Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665
[TBL] [Abstract][Full Text] [Related]
11. Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells.
Chu PM; Chen LH; Chen MT; Ma HI; Su TL; Hsieh PC; Chien CS; Jiang BH; Chen YC; Lin YH; Shih YH; Tu PH; Chiou SH
Cancer Chemother Pharmacol; 2012 Mar; 69(3):621-33. PubMed ID: 21947203
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of pyrazolo[3,4-g]quinoxaline derivatives.
Gavara L; Saugues E; Alves G; Debiton E; Anizon F; Moreau P
Eur J Med Chem; 2010 Nov; 45(11):5520-6. PubMed ID: 20864224
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2009 Dec; 17(23):7909-14. PubMed ID: 19875299
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-glioma activity of 25(R)-spirostan-3beta,5alpha,6beta,19-tetrol.
Leng T; Zhang J; Xie J; Zhou S; Huang Y; Zhou Y; Zhu W; Yan G
Steroids; 2010 Mar; 75(3):224-9. PubMed ID: 20026149
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell cycle progression by penta-acetyl geniposide in rat C6 glioma cells.
Chang YC; Chou FP; Huang HP; Hsu JD; Wang CJ
Toxicol Appl Pharmacol; 2004 Jul; 198(1):11-20. PubMed ID: 15207644
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
Ethiraj KR; Aranjani JM; Khan FR
Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of in vitro and in vivo anticancer activities of polysaccharide peptide from Grifola frondosa by chemical modifications.
Chan JY; Chan E; Chan SW; Sze SY; Chan MF; Tsui SH; Leung KY; Chan RY; Chung IY
Pharm Biol; 2011 Nov; 49(11):1114-20. PubMed ID: 21595572
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents.
Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN
Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
20. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
Cabrera M; Simoens M; Falchi G; Lavaggi ML; Piro OE; Castellano EE; Vidal A; Azqueta A; Monge A; de Ceráin AL; Sagrera G; Seoane G; Cerecetto H; González M
Bioorg Med Chem; 2007 May; 15(10):3356-67. PubMed ID: 17383189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
